Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 16q24 3 Microdeletion Syndrome C4304594
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 16q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
16q24 3 Microdeletion Syndrome C4304594
A genetic condition resulting from deletion of a small segment on chromosome 16. Affected individuals may have developmental delays and physical differences. Care is individualized based on specific needs.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
16q24 3 Microdeletion Syndrome C4304594
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
16q24 3 Microdeletion Syndrome C4304594
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
16q24 3 Microdeletion Syndrome C4304594
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
16q24 3 Microdeletion Syndrome C4304594
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
16q24 3 Microdeletion Syndrome C4304594
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
16q24 3 Microdeletion Syndrome C4304594
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 16q24-3-microdeletion-syndrome-C4304594 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16q24 3 Microdeletion Syndrome C4304594 | Discriminating power |
|---|---|---|---|
| Developmental delay | May occur and is described with possible intellectual disability. | May occur; intellectual disability is not specified in the source. | Low |
| Physical differences | Distinctive facial features are mentioned, but details are not established. | Physical differences may occur without a specified pattern here. | Low |
| Overall severity | Labeled severe in the supplied data. | Labeled moderate in the supplied data. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
A confirmed deletion involving the stated chromosome 21 region
The chromosomal locus, not symptoms alone, distinguishes the condition.
High
Developmental delay with possible intellectual disability and facial differences
These features are mentioned for the left condition but are not diagnostic alone.
Low
Need for intensive developmental support
The supplied severity is severe, though individual needs vary.
Moderate
Choose 16q24 3 Microdeletion Syndrome C4304594 when
A confirmed 16q24.3 microdeletion
Genetic confirmation of the chromosome 16 segment is the key distinction.
High
Developmental delay with unspecified physical differences
This matches the limited source description but does not prove the diagnosis.
Low
Individualized care for a moderate congenital condition
The source labels severity moderate and emphasizes needs-based care.
Moderate
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16q24 3 Microdeletion Syndrome C4304594 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a deletion in the stated chromosome 21 region. | May identify a small 16q24.3 deletion. | The deleted locus distinguishes the conditions; clinician and laboratory interpretation is required. |
| Developmental assessment | May document delay and possible intellectual disability. | May document developmental delay. | Findings overlap and cannot replace genetic confirmation. |
| Clinical dysmorphology examination | May note distinctive facial features if present. | May note physical differences without a defined pattern here. | Examination supports evaluation but is not definitive from these data. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- A chronic congenital condition labeled severe; exact outcomes are not established.
- Factors
- Deletion confirmation, developmental profile, and associated medical findings.
16q24 3 Microdeletion Syndrome C4304594
- Outcome
- A chronic congenital condition labeled moderate; exact outcomes are not established.
- Factors
- Deletion confirmation and each person's developmental and physical needs.
Time frame: Often recognized in early life, with lifelong follow-up; precise onset data are incomplete.
Individual findings matter more than the category label; clinician interpretation is required.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning and developmental needs | Possible developmental delay and intellectual disability. Possible developmental delay; cognitive outcome is not specified. Support needs should be assessed individually. |
| Physical or congenital differences | Distinctive facial features are mentioned. Physical differences may be present. Exact associated anomalies are not established in the source. |
| Long-term medical complexity | Labeled severe and chronic, so monitoring may be substantial. Labeled moderate and chronic, with individualized care. Neither label predicts a specific complication rate. |
Patient education highlights
- HighGenetic confirmation
Ask which chromosome region was deleted and request a copy of the laboratory report.
- HighSupportive care
Care focuses on developmental support and monitoring; no treatment dose is established here.
- MediumVariable presentation
Features and severity can vary, and overlapping symptoms do not identify the deletion.